Rooster Bio enters into strategic licensing agreement with Nikon Cell Innovation

Big news from Dynamk Capital portfolio company Rooster Bio! Their strategic licensing agreement with Nikon Cell Innovation marks a major step forward in expanding access to GMP-grade MSCs and extracellular vesicles in Japan. This collaboration underscores the growing global impact of MSCs in regenerative medicine and RoosterBio’s leadership in scalable, clinical-grade biomanufacturing solutions.